Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Ireland / NCT06587321
Recruiting Observational

Remote Assessment of Signs and Symptoms in Palliative Care

NCT06587321 · tracked via the Priya Life Science Ireland tracker
Sponsor
Our Lady's Hospice and Care Services
Phase
Observational
Started
2024-04-01
Last updated
2025-06-27

Condition(s) studied

Palliative CareVital SignsRemote Monitoring

Study summary

Digital health interventions, including remote monitoring of patients, have been identified as a possible way to address current problems within the health service, including insufficient numbers of staff, and an increasing number of patients requiring services.

The aim of this study is to assess the feasibility of using remote monitoring for patients who are receiving palliative care and to see whether remote monitoring can improve care and outcomes for patients and their families.

Participants in this study will complete regular (daily, weekly, monthly) questionnaires online about how they are feeling. They will also be given equipment to measure their vital signs every day. The clinical team will have access to the results and be able to respond to any new problems as they arise. Patients and their carers will then complete a questionnaire at one month to assess satisfaction with the use of remote monitoring.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Primary diagnosis of advanced cancer or another life-limiting condition * Estimated prognosis greater than 3 months * Referred for community-based specialist palliative care * Living in own home (or home of family carer) * Living with a family carer Exclusion Criteria: * Estimated prognosis less than 3 months or more than 12 months * Cognitive impairment - unable to provide consent / complete assessments * Non-English speaker * Living in care home / nursing home / hospice / community hospital * Not living with a family carer

Primary outcome measure(s)

  • Completion rates of assessments — At the end of 1 month
    Number of assessments completed over the study time-frame

Trial sites (1)

FacilityCityRegionStatus
Our Lady's Hospice & Care Services Dublin Dublin Recruiting

More Our Lady's Hospice and Care Services trials in Ireland

Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor Recruiting
Palliative Care and Oncology Survey on Terminology Recruiting
Cognition in Older Adults With Cancer Receiving Systemic Anti-Cancer Therapy Active, not recruiting
Sleep Well At Night Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06587321 on ClinicalTrials.gov ↗ ← All trials in Ireland